PSIJX
Price
$9.47
Change
+$0.11 (+1.18%)
Updated
Jun 2 closing price
Net Assets
2.48B
WCMNX
Price
$14.98
Change
+$0.18 (+1.22%)
Updated
Jun 2 closing price
Net Assets
52.45M
Interact to see
Advertisement

PSIJX vs WCMNX

Header iconPSIJX vs WCMNX Comparison
Open Charts PSIJX vs WCMNXBanner chart's image
PSIJX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
PSIJX vs. WCMNX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSIJX is a Hold and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PSIJX has more cash in the bank: 2.48B vs. WCMNX (52.4M). PSIJX (0.00) and WCMNX (0.00) have matching dividends . PSIJX was incepted earlier than WCMNX: PSIJX (25 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than PSIJX (1.16). WCMNX is a more actively managed with annual turnover of: 89.00 vs. PSIJX (70.10). PSIJX (1000) and WCMNX (1000) have matching initial minimum investment requirements. WCMNX annual gain was more profitable for investors over the last year : 25.42 vs. PSIJX (18.93). WCMNX return over 5 years is better than : -1.40 vs. PSIJX (-22.88).
PSIJXWCMNXPSIJX / WCMNX
Total Expense Ratio1.141.2492%
Annual Report Gross Expense Ratio1.162.0457%
Fund Existence25 years7 years-
Gain YTD18.6319.225202%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.48B52.4M4,727%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.9325.4274%
Returns for 3 years21.5931.2169%
Returns for 5 years-22.88-1.401,635%
Returns for 10 years11.41N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IILGX32.710.13
+0.40%
Thrivent Global Stock S
BLDRX9.740.01
+0.10%
BlackRock Managed Income K
RYENX313.96N/A
N/A
Rydex Energy A
FPACX45.31N/A
N/A
FPA Crescent
NSCCX43.02N/A
N/A
Nuveen Small-Cap Value Opps C